Okazaki K, Yokoyama Y, Yamamoto Y, Kobayashi M, Araki K, Ogata T
First Department of Internal Medicine, Kochi Medical School, Japan.
J Gastroenterol. 1994 Aug;29(4):415-22. doi: 10.1007/BF02361237.
We report a 27-year-old male with Crohn's disease (CD) of the small and large intestine, whose peripheral blood lymphocytes (PBL) showed increased cell-mediated cytotoxicity (CTL). Autologous and allogeneic effector cells from PBL and intestinal lymph nodes (LN) were isolated on a Ficoll-Hypaque gradient. Colonic cells were prepared as the target and were incubated for 6h with effector cells, after being labeled with Na(2)51CrO4. The CTL activity [effector/target (E/T) ratio, 100:1] of PBL for autologous targets was increased by 38% compared with that in normal subjects (< 10%), while that shown by LN was not increased (14%). The CTL activity of allogeneic PBL prepared from three of four other CD patients was also increased. Anti-major histocompatibility (MHC) class I and II and CD4 and CD8 monoclonal antibodies (50 micrograms/ml) significantly inhibited CTL activity. Complement-mediated depletion of CD2+ cells significantly reduced CTL activity. These results suggest that MHC-restricted CTL may play a role in mucosal damage in some patients with Crohn's disease.
我们报告了一名患有小肠和大肠克罗恩病(CD)的27岁男性,其外周血淋巴细胞(PBL)显示细胞介导的细胞毒性(CTL)增加。通过Ficoll-Hypaque梯度分离来自PBL和肠淋巴结(LN)的自体和同种异体效应细胞。将结肠细胞制备为靶细胞,并用Na(2)51CrO4标记后,与效应细胞孵育6小时。与正常受试者(<10%)相比,PBL对自体靶细胞的CTL活性[效应细胞/靶细胞(E/T)比率,100:1]增加了38%,而LN显示的CTL活性未增加(14%)。从其他四名CD患者中的三名制备的同种异体PBL的CTL活性也增加。抗主要组织相容性(MHC)I类和II类以及CD4和CD8单克隆抗体(50微克/毫升)显著抑制CTL活性。补体介导的CD2+细胞耗竭显著降低了CTL活性。这些结果表明,MHC限制的CTL可能在一些克罗恩病患者黏膜损伤中起作用。